[Ambulatory blood pressure monitoring in diabetic hypertensive patients].

Harefuah

Department of Obstetrics and Gynecology, Barzilay Hospital, Ashkelon, Israel.

Published: January 2007

This study aimed to evaluate the frequency of attenuated decline in nocturnal blood pressure (BP) in diabetic hypertensive patients, and characterize those who don't decrease BP during nighttime. A total of 61 hypertensive patients (26 males and 35 females, mean age 65.8+/-10) were included in the study. Patients were defined as hypertensive if their daytime pressure exceeded 140/90 (the definition relevant at the time of our study) or if they were on antihypertensive treatment. All patients underwent 24 hour Ambulatory BP Monitoring (ABPM) using Suntech Accutracker Dx. Subjects with nocturnal fall in SBP, DBP or MAP of less than 10% of daytime values were classified as non-dippers. Echocardiography and renal function were also evaluated. Two thirds of the subjects were non-dippers. The percentage of dippers among women was higher than that observed in men: SBP 34% versus 19% and DBP 48% versus 38% (the difference is statistically significant with p< 0.01). Non-significant correlation was observed between absence of nocturnal decline, age and gender. The 24 hour ABPM measurements should be recommended in all diabetic hypertensive patients in whom aggressive treatment covering nighttime should be offered.

Download full-text PDF

Source

Publication Analysis

Top Keywords

diabetic hypertensive
12
hypertensive patients
12
blood pressure
8
hypertensive
5
patients
5
[ambulatory blood
4
pressure monitoring
4
monitoring diabetic
4
hypertensive patients]
4
patients] study
4

Similar Publications

Stroke is one of the leading causes of death in developing countries, and China bears the largest global burden of stroke. This study aims to investigate the relationship between different dimensions of physical activity levels and stroke risk using a nationally representative database. We performed a cross-sectional analysis using data from the China Health and Retirement Longitudinal Study (CHARLS) 2020.

View Article and Find Full Text PDF

Excessive daytime sleepiness and its predictors among type 2 diabetes mellitus patients at central ethiopia.

Sci Rep

December 2024

Department of Pediatrics and Child Health Nursing, College of Medicine and Health Sciences, Injibara University, Injibara, Ethiopia.

Excessive daytime sleepiness is a common finding among type 2 diabetes mellitus patients. However there is scarce data that shows the magnitude of excessive daytime sleepiness, & its association with type 2 diabetes mellitus. Hence, the study aimed to assess the prevalence of excessive daytime sleepiness and its associated factors among type 2 diabetes mellitus patients at Wolkite University Specialized Hospital.

View Article and Find Full Text PDF

The unintended consequences of polypharmacy pose significant risks to older adults. The complexities of managing numerous medications from multiple prescribers demand a comprehensive approach to mitigate harms. Pharmacist-led clinics have been shown to improve outcomes in patients with diabetes and hypertension.

View Article and Find Full Text PDF

The evolving concepts of KS-WNK1 effect on NCC activity.

Am J Physiol Renal Physiol

December 2024

Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, 14080 Mexico.

The field of the with no lysine kinases (WNKs) regulation of the thiazide-sensitive NaCl cotransporter (NCC) began at the start of the century with the discovery that mutations in two members of the family, WNK1 and WNK4, resulted in a condition known as Familiar Hyperkalemic Hypertension (FHHt). Since FHHt is the mirror image of Gitelman's syndrome that is caused by inactivating mutations of the SLC12A3 gene encoding NCC, it was expected that WNKs modulated NCC activity and that the increased function of the cotransporter is the pathophysiological mechanism of FFHt. This turned out to be the case.

View Article and Find Full Text PDF

Objectives The study was conducted to generate real-world data on prescription patterns and patient profiles for sitagliptin-based therapies in real-world outpatient settings across India. Method A cross-sectional, observational, multicenter, real-world prescription event monitoring (PEM) study was conducted at 1058 sites across India over six months, from 1 August 2023 to 16 January 2024. Adult type 2 diabetes patients receiving sitagliptin-based mono or combination therapies were included in the study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!